IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - Euronext Lisbon - ELI:IBS - PTIBS0AM0008 - Common Stock
10.45 EUR
+0.05 (+0.48%)
We assign a fundamental rating of 4 out of 10 to IBS. IBS was compared to 62 industry peers in the Hotels, Restaurants & Leisure industry. IBS has an average financial health and profitability rating. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year IBS was profitable.
- IBS had a positive operating cash flow in the past year.
- Of the past 5 years IBS 4 years were profitable.
- Each year in the past 5 years IBS had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 1.91%, IBS is in line with its industry, outperforming 43.33% of the companies in the same industry.
- With a Return On Equity value of 4.21%, IBS perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
- The Return On Invested Capital of IBS (4.53%) is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for IBS is significantly below the industry average of 12.01%.
- The last Return On Invested Capital (4.53%) for IBS is above the 3 year average (3.32%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.91% | ||
| ROE | 4.21% | ||
| ROIC | 4.53% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.56%, IBS is in line with its industry, outperforming 45.00% of the companies in the same industry.
- In the last couple of years the Profit Margin of IBS has declined.
- IBS has a Operating Margin of 5.83%. This is comparable to the rest of the industry: IBS outperforms 46.67% of its industry peers.
- In the last couple of years the Operating Margin of IBS has declined.
- With a Gross Margin value of 52.62%, IBS perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
- In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.83% | ||
| PM (TTM) | 2.56% | ||
| GM | 52.62% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
- Compared to 1 year ago, IBS has less shares outstanding
- Compared to 5 years ago, IBS has more shares outstanding
- Compared to 1 year ago, IBS has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.13 indicates that IBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.13, IBS perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
- IBS has a debt to FCF ratio of 3.47. This is a good value and a sign of high solvency as IBS would need 3.47 years to pay back of all of its debts.
- The Debt to FCF ratio of IBS (3.47) is better than 71.67% of its industry peers.
- A Debt/Equity ratio of 0.66 indicates that IBS is somewhat dependend on debt financing.
- The Debt to Equity ratio of IBS (0.66) is better than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 3.47 | ||
| Altman-Z | 2.13 |
ROIC/WACC0.73
WACC6.25%
2.3 Liquidity
- A Current Ratio of 1.02 indicates that IBS should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.02, IBS is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- A Quick Ratio of 0.92 indicates that IBS may have some problems paying its short term obligations.
- IBS has a Quick ratio of 0.92. This is comparable to the rest of the industry: IBS outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
- The earnings per share for IBS have decreased strongly by -16.66% in the last year.
- The Earnings Per Share has been decreasing by -8.23% on average over the past years.
- Looking at the last year, IBS shows a quite strong growth in Revenue. The Revenue has grown by 15.02% in the last year.
- IBS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.46% yearly.
EPS 1Y (TTM)-16.66%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%83.33%
Revenue 1Y (TTM)15.02%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%7.53%
3.2 Future
- The Earnings Per Share is expected to grow by 17.57% on average over the next years. This is quite good.
- The Revenue is expected to grow by 7.42% on average over the next years.
EPS Next Y-38.06%
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
EPS Next 5Y17.57%
Revenue Next Year15.95%
Revenue Next 2Y10.49%
Revenue Next 3Y8.64%
Revenue Next 5Y7.42%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- IBS is valuated quite expensively with a Price/Earnings ratio of 30.74.
- IBS's Price/Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, IBS is valued at the same level.
- Based on the Price/Forward Earnings ratio of 33.02, the valuation of IBS can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IBS is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of IBS to the average of the S&P500 Index (25.98), we can say IBS is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.74 | ||
| Fwd PE | 33.02 |
4.2 Price Multiples
- IBS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IBS is cheaper than 88.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.24 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
5. Dividend
5.1 Amount
- IBS has a Yearly Dividend Yield of 6.73%, which is a nice return.
- Compared to an average industry Dividend Yield of 1.36, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.73% |
5.2 History
- The dividend of IBS is nicely growing with an annual growth rate of 48.65%!
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- IBS pays out 213.50% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of IBS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP213.5%
EPS Next 2Y-0.66%
EPS Next 3Y2.31%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
Can you provide the valuation status for IBERSOL SGPS SA?
ChartMill assigns a valuation rating of 2 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
What is the financial health of IBERSOL SGPS SA (IBS.LS) stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
Can you provide the dividend sustainability for IBS stock?
The dividend rating of IBERSOL SGPS SA (IBS.LS) is 6 / 10 and the dividend payout ratio is 213.5%.